Mounjaro (tirzepatide) is a weekly injection for weight management that works differently from earlier GLP-1 medications. While semaglutide (Wegovy, Ozempic) targets a single hormone receptor, tirzepatide targets two - GLP-1 and GIP - giving it a dual mechanism of action. In Singapore, it is available as a prescription medication and has become an increasingly discussed option for medically supervised weight management.
Quick factsDrug name: TirzepatideBrand name: MounjaroMechanism: Dual GLP-1 / GIP receptor agonistDose form: Weekly subcutaneous injectionAvailable doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mgPrescription required: YesHow tirzepatide worksGLP-1 (glucagon-like peptide-1) is a gut hormone that signals fullness to the brain, slows gastric emptying, and helps regulate blood sugar. GIP (glucose-dependent insulinotropic polypeptide) is a second gut hormone that also plays a role in fat metabolism and
...